Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Michael Palese, MD

Advertisement

Articles by Michael Palese, MD

Michael A. Palese, MD

Dr. Palese on Emerging Technologies in Benign Prostatic Hyperplasia

ByMichael Palese, MD
September 10th 2021

Michael A. Palese, MD, discusses emerging technologies in benign prostatic hyperplasia.

Ablative Therapies for Small Renal Masses

ByBy Kadi-Ann Harvey-Bryan, MD,Michael Palese, MD
May 22nd 2013

A peer-reviewed summary of the ablative techniques currently available for the treatment of small renal masses.

Advertisement

Latest Updated Articles

  • Michael A. Palese, MD
    Dr. Palese on Emerging Technologies in Benign Prostatic Hyperplasia

    September 10th 2021

  • Ablative Therapies for Small Renal Masses
    Ablative Therapies for Small Renal Masses

    May 22nd 2013



Advertisement
Advertisement

Trending on OncLive

1

FDA Approves Bioequivalent Olaparib Across Previously Approved Cancer Indications

2

Longer-Term Data Help Shape TKI Selection in ROS1+ and ALK+ NSCLC

3

Experts Revisit the Most Notable Data in GU Oncology From ASCO 2026

4

Alpha DaRT Plus Pembrolizumab Yields 100% ORR in Elderly Recurrent or Metastatic HNSCC

5

EO2463-Induced CD8 T-Cell Expansion Correlates With Survival Outcomes in Indolent NHL

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us